PATENT CLAIM ANALYSIS

Application Number: 16031250
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "360000"]

Abstract:
Methods of treating mental disorders, including anxiety disorders such as obsessive-compulsive disorder, are provided. The methods comprise administering an effective amount of a glutamate modulator to an individual in need thereof. Also provided are methods of enhancing the activity of a serotonin reuptake inhibitor (SRI) comprising co-administering a glutamate modulator and a serotonin reuptake inhibitor. Pharmaceutical composition comprising a serotonin reuptake inhibitor and a glutamate modulator are also provided.

Claim (Index 35):
A method of treating a mental disorder in an individual in need thereof comprising administering to said individual an effective amount of riluzole in pharmaceutical dosage form in combination with at least one pharmaceutically acceptable carrier for administration via oral, buccal, vaginal, rectal or topical route of administration, wherein said mental disorder is post-traumatic stress disorder, social anxiety disorder, panic disorder, eating disorder, trichotillomania, skin-picking disorder, schizophrenia, dementia, Alzheimer's disease or obsessive compulsive disorder.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 95.0
- Lexical Diversity: 1.67391
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14278573', '11399188', '11591244', '13887901', '14022804']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7554218197315958
- 35 USC 102 Novelty (BERT): 0.6103305243754162
- Combined Prediction Score: 0.7409126901959779
- Mean Citation Score: 389.055668
- Max Citation Score: 599.818
- Similarity Product: 468.7473165652752

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test